Study of the effectiveness of Voriconazole in the treatment of Aspergillus fumigatus associated asthma - Effectiveness of Voriconazole in Aspergillus associated asthma
Phase 1
- Conditions
- Asthma with sensitization to aspergillus and isolation in sputum.
- Registration Number
- EUCTR2009-011452-21-GB
- Lead Sponsor
- niversity Hospitals of Leicester NHS trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inclusion criteria
Aged 18 and over
Able to give consent
Diagnosis of asthma and fungal sensitization or allergic bronchopulmonary aspergillosis.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Exclusion criteria
Age under 18
Unable to give informed consent
A principle diagnosis of COPD or bronchiectasis
History of non compliance with medication, or unable to produce sputum.
A co-morbid condition likely to increase the risk of side effects
Pregnancy or possibility of becoming pregnant during the treatment phase of the study.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method